Revision of the concept of anti-angiogenesis and its applications in tumor treatment
Anti-angiogenesis therapy, by blocking formation of new blood vessels in tumors, is the standard-of-care therapy for various cancer types. The classic concept of anti-angiogenesis is expected to turn a tumor into a âdormantâ disease. However, the combination of anti-angiogenesis agents with conventi...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2017-03-01
|
Series: | Chronic Diseases and Translational Medicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2095882X16300998 |
id |
doaj-17226f6351f3463cb5a27d872c318c54 |
---|---|
record_format |
Article |
spelling |
doaj-17226f6351f3463cb5a27d872c318c542021-03-02T09:26:27ZengKeAi Communications Co., Ltd.Chronic Diseases and Translational Medicine2095-882X2017-03-01313340Revision of the concept of anti-angiogenesis and its applications in tumor treatmentWen-Hui Yang0Jun Xu1Jian-Bing Mu2Jun Xie3Department of Biochemistry and Molecular Biology, Shanxi Medical University, Taiyuan, Shanxi 030001, China; Tumor Hospital of Shanxi Province, Taiyuan, Shanxi 030013, ChinaTumor Hospital of Shanxi Province, Taiyuan, Shanxi 030013, China; Corresponding author.Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USADepartment of Biochemistry and Molecular Biology, Shanxi Medical University, Taiyuan, Shanxi 030001, China; Corresponding author.Anti-angiogenesis therapy, by blocking formation of new blood vessels in tumors, is the standard-of-care therapy for various cancer types. The classic concept of anti-angiogenesis is expected to turn a tumor into a âdormantâ disease. However, the combination of anti-angiogenesis agents with conventional therapeutics has generally produced only modest survival benefits for cancer patients in clinical trials. Therefore, the concept and applications of anti-angiogenesis have evolved dramatically along with lessons learned from recent clinical experience. In this article, we will discuss the revised concept of anti-angiogenesis therapy and the applications of anti-angiogenesis drugs, and focus particularly on how to utilize current anti-angiogenesis agents and develop new approaches to provide more benefits to patients with cancer. Keywords: Anti-angiogenesis, Angiogenesis, Vascular endothelial growth factor, Cancerhttp://www.sciencedirect.com/science/article/pii/S2095882X16300998 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Wen-Hui Yang Jun Xu Jian-Bing Mu Jun Xie |
spellingShingle |
Wen-Hui Yang Jun Xu Jian-Bing Mu Jun Xie Revision of the concept of anti-angiogenesis and its applications in tumor treatment Chronic Diseases and Translational Medicine |
author_facet |
Wen-Hui Yang Jun Xu Jian-Bing Mu Jun Xie |
author_sort |
Wen-Hui Yang |
title |
Revision of the concept of anti-angiogenesis and its applications in tumor treatment |
title_short |
Revision of the concept of anti-angiogenesis and its applications in tumor treatment |
title_full |
Revision of the concept of anti-angiogenesis and its applications in tumor treatment |
title_fullStr |
Revision of the concept of anti-angiogenesis and its applications in tumor treatment |
title_full_unstemmed |
Revision of the concept of anti-angiogenesis and its applications in tumor treatment |
title_sort |
revision of the concept of anti-angiogenesis and its applications in tumor treatment |
publisher |
KeAi Communications Co., Ltd. |
series |
Chronic Diseases and Translational Medicine |
issn |
2095-882X |
publishDate |
2017-03-01 |
description |
Anti-angiogenesis therapy, by blocking formation of new blood vessels in tumors, is the standard-of-care therapy for various cancer types. The classic concept of anti-angiogenesis is expected to turn a tumor into a âdormantâ disease. However, the combination of anti-angiogenesis agents with conventional therapeutics has generally produced only modest survival benefits for cancer patients in clinical trials. Therefore, the concept and applications of anti-angiogenesis have evolved dramatically along with lessons learned from recent clinical experience. In this article, we will discuss the revised concept of anti-angiogenesis therapy and the applications of anti-angiogenesis drugs, and focus particularly on how to utilize current anti-angiogenesis agents and develop new approaches to provide more benefits to patients with cancer. Keywords: Anti-angiogenesis, Angiogenesis, Vascular endothelial growth factor, Cancer |
url |
http://www.sciencedirect.com/science/article/pii/S2095882X16300998 |
work_keys_str_mv |
AT wenhuiyang revisionoftheconceptofantiangiogenesisanditsapplicationsintumortreatment AT junxu revisionoftheconceptofantiangiogenesisanditsapplicationsintumortreatment AT jianbingmu revisionoftheconceptofantiangiogenesisanditsapplicationsintumortreatment AT junxie revisionoftheconceptofantiangiogenesisanditsapplicationsintumortreatment |
_version_ |
1724239357074735104 |